Maria Fardis

2019

In 2019, Maria Fardis earned a total compensation of $4.1M as President and Chief Executive Officer at Lion Biotechnologies, a 56% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$600,000
Option Awards$2,907,960
Salary$600,000
Total$4,107,960

Fardis received $2.9M in option awards, accounting for 71% of the total pay in 2019.

Fardis also received $600K in non-equity incentive plan and $600K in salary.

Rankings

In 2019, Maria Fardis' compensation ranked 2,882nd out of 13,971 executives tracked by ExecPay. In other words, Fardis earned more than 79.4% of executives.

ClassificationRankingPercentile
All
2,882
out of 13,971
79th
Division
Manufacturing
1,040
out of 5,695
82nd
Major group
Chemicals And Allied Products
346
out of 2,194
84th
Industry group
Drugs
283
out of 1,880
85th
Industry
Biological Products, Except Diagnostic Substances
67
out of 389
83rd
Source: SEC filing on April 27, 2021.

Fardis' colleagues

We found three more compensation records of executives who worked with Maria Fardis at Lion Biotechnologies in 2019.

2019

Friedrich Finckenstein

Lion Biotechnologies

Chief Medical Officer

2019

Frederick Vogt

Lion Biotechnologies

General Counsel

2019

Timothy Morris

Lion Biotechnologies

Chief Financial Officer

News

In-depth

You may also like